NCT04880174View on ClinicalTrials.gov

SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel Following mRNA COVID-19 Vaccination

NAActive, not recruitingINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

March 22, 2021

Primary Completion Date

July 31, 2028

Study Completion Date

July 31, 2028

Conditions
SARS-CoV Infection
Interventions
DIAGNOSTIC_TEST

serological testing

Antibody testing for Sars-COV-2 antibodies in blood.

Trial Locations (1)

1090

Universitair ziekenhuis Brussel, Brussels

All Listed Sponsors
lead

Universitair Ziekenhuis Brussel

OTHER